Anti-HIV compounds
US11052087B2 · kind B2 · utility
0Cited by
13References
86Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2019 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | Jul 29, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds having Formula (I): or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising the same, processes for their preparation, and methods of treating and preventing HIV infection by their administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.